• bitcoinBitcoin(BTC)$83,939.00-0.29%
  • ethereumEthereum(ETH)$2,693.970.95%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$773.64-0.47%
  • rippleXRP(XRP)$1.585.26%
  • usd-coinUSDC(USDC)$1.000.01%
  • solanaSolana(SOL)$119.584.03%
  • tronTRON(TRX)$0.337491-0.70%
  • zcashZcash(ZEC)$1,591.144.83%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.03-0.87%
  • HyperliquidHyperliquid(HYPE)$92.06-0.51%
  • dogecoinDogecoin(DOGE)$0.0977843.75%
  • chainlinkChainlink(LINK)$13.9611.45%
  • moneroMonero(XMR)$549.46-0.38%
  • whitebitWhiteBIT Coin(WBT)$83.85-0.46%
  • USDSUSDS(USDS)$1.00-0.01%
  • cardanoCardano(ADA)$0.2546365.27%
  • RainRain(RAIN)$0.011863-1.52%
  • leo-tokenLEO Token(LEO)$8.84-0.63%
  • stellarStellar(XLM)$0.2189206.94%
  • nearNEAR Protocol(NEAR)$5.1513.67%
  • bitcoin-cashBitcoin Cash(BCH)$333.29-1.59%
  • uniswapUniswap(UNI)$9.685.33%
  • litecoinLitecoin(LTC)$69.84-1.27%
  • Ethena USDeEthena USDe(USDE)$1.00-0.01%
  • CantonCanton(CC)$0.12320912.40%
  • avalanche-2Avalanche(AVAX)$10.370.91%
  • daiDai(DAI)$1.000.02%
  • suiSui(SUI)$1.1212.52%
  • USD1USD1(USD1)$1.000.02%
  • hedera-hashgraphHedera(HBAR)$0.0943431.49%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.420.37%
  • shiba-inuShiba Inu(SHIB)$0.0000062.29%
  • BittensorBittensor(TAO)$302.944.97%
  • crypto-com-chainCronos(CRO)$0.0657216.66%
  • Global DollarGlobal Dollar(USDG)$1.000.02%
  • BitwayBitway(BTW)$1.1812.46%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • MemeCoreMemeCore(M)$1.18-2.97%
  • OndoOndo(ONDO)$0.5511.76%
  • tether-goldTether Gold(XAUT)$4,268.20-0.02%
  • okbOKB(OKB)$119.960.72%
  • EthenaEthena(ENA)$0.24574112.25%
  • Circle USYCCircle USYC(USYC)$1.140.03%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$147.924.23%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.140.05%
  • mantleMantle(MNT)$0.67-2.35%
  • polkadotPolkadot(DOT)$1.182.02%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

FDA says some cold and allergy drugs have an ineffective key ingredient

November 22, 2024
in Market & News
Reading Time: 1 min read
A A
ShareShareShareShareShare



There are new concerns that phenylephrine, an ingredient in common over-the-counter cold and allergy medicines is ineffective. The FDA said the ingredient is safe but many popular medicines are being pulled off the shelves. NBC News’ Dr. Vin Gupta reports on what companies are doing next.

» Subscribe to NBC News:
» Watch more NBC video:

YOU MAY ALSO LIKE

Meet the Press Full Episode — August 23

Credo: The Rise Of Muse Validates The AI Trade (NASDAQ:CRDO)

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App:
Breaking News Alerts:
Visit NBCNews.Com:
Find NBC News on Facebook:
Follow NBC News on Twitter:
Follow NBC News on Instagram:

#Phenylephrine #DFA #ColdMedicine

source

ShareTweetSendSharePin

Related Posts

Meet the Press Full Episode — August 23
Market & News

Meet the Press Full Episode — August 23

September 25, 2026
Credo: The Rise Of Muse Validates The AI Trade (NASDAQ:CRDO)
Market & News

Credo: The Rise Of Muse Validates The AI Trade (NASDAQ:CRDO)

September 25, 2026
Trump says D.C. Grand Prix is bigger than ‘we ever thought possible’
Market & News

Trump says D.C. Grand Prix is bigger than ‘we ever thought possible’

September 25, 2026
Some dementia patients grow lucid near the end. Scientists hope it’s a clue. – The Washington Post
Market & News

Some dementia patients grow lucid near the end. Scientists hope it’s a clue. – The Washington Post

September 25, 2026
Next Post
Supplement sold on Amazon recalled due to contamination with ‘hidden drug’

Supplement sold on Amazon recalled due to contamination with 'hidden drug'

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Pfizer: A Conservative Valuation Leaves Room For A Post-LOE Re-Rating

Pfizer: A Conservative Valuation Leaves Room For A Post-LOE Re-Rating

September 22, 2026
Meta Brings FDA-Cleared Hearing Enhancement To Its Smart Glasses

Meta Brings FDA-Cleared Hearing Enhancement To Its Smart Glasses

September 23, 2026
CNX Resources: Use The Time Left To Head To Industry Leaders And Cash (NYSE:CNX)

CNX Resources: Use The Time Left To Head To Industry Leaders And Cash (NYSE:CNX)

September 19, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!